"It has been my great honor to serve as Gilead's CFO for more than 10 years, and to work alongside the talented team we have in place across our CFO organization and Gilead at large. Together, we've played a role in the important work this company does to deliver ground-breaking treatment advances to people all over the world," said Ms. Washington. "I am committed to working with Dan, the rest of the leadership team and my colleagues over the coming months to ensure that this transition process is a seamless one." As previously announced, Gilead is reporting first quarter 2019 earnings results on May 2, 2019. – Gilead